Case StudiesHudson Labs predicted iLearningEngines ($AILE) stock collapseHudson Labs Labs used specialized AI to identify red flags and predict stock collapse of iLearningEngines AILE.Julia Xu, Chief of Staff at Hudson Labs·Dec 27, 2024·3 min read
Case StudiesField notes on four quantum computing companiesHudson Labs highlight four quantum computing companies with high Hudson Labs forensic risk scores, including D-Wave Quantum QBTS, Rigetti RGTI, IonQ, and QUBTJulia Xu, Chief of Staff at Hudson Labs·Dec 13, 2024·4 min read
Case StudiesHudson Labs Research & StudiesHudson Labs has state-of-art research and development in financial AIJulia Xu, Chief of Staff at Hudson Labs·Dec 10, 2024·2 min read
Case StudiesHudson Labs predicted Cano Health's (CANO) stock collapse Bedrock AI was predicting a collapse at Cano Health as early as August 16, 2021, . When the company’s risk score was 76 (very high risk).Andre Castillo, Head of Forensic Research at Hudson Labs·Dec 12, 2022·3 min read
Case StudiesHudson Labs predicted Opendoor Technologies' (OPEN) stock collapse Bedrock AI was predicting collapse at Opendoor as early as March 2021 when the company’s risk score, , increased from 53 to 81 (very high risk).Andre Castillo, Head of Forensic Research at Hudson Labs·Dec 12, 2022·3 min read
Case StudiesHudson Labs predicted Robinhood's (HOOD) stock collapseBedrock AI predicted Robinhood's stock price would collapse as early as August 2021 when the company’s risk score, reached 78 (very high risk)Andre Castillo, Head of Forensic Research at Hudson Labs·Dec 9, 2022·3 min read
Case StudiesHudson Labs predicted Core Scientific's (CORZQ) stock collapse and bankruptcy Bedrock AI predicted a price collapse at Core Scientific as early as March 2022 with a “very high risk” score. Andre Castillo, Head of Forensic Research at Hudson Labs·Dec 7, 2022·3 min read
Case StudiesHudson Labs predicted Coinbase's stock collapseBedrock AI predicted a price collapse at COIN as early as May 2021 with a “very high risk” score, top10% highest scores at mid/high cap companies. Andre Castillo, Head of Forensic Research at Hudson Labs·Dec 6, 2022·3 min read
Case StudiesA Hard Day at Rafael Rafael was heavily dependent on the success of Rafael Parmaceutical’s CPI-613 product. The trial was not successful. Investors lost over $400M.Andre Castillo, Head of Forensic Research at Hudson Labs·Oct 29, 2022·3 min read